Stock CTGL CITRINE GLOBAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Citrine Global Corp.

Equities

CTGL

US17737V1052

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 03:11:46 2024-04-15 pm EDT 		5-day change 1st Jan Change
0.0125 USD +4.17% Intraday chart for Citrine Global Corp. 0.00% -37.50%
Feb. 23 Citrine Global Corp. Announces Resignation of Mr. Doron Birger from the Board CI
Feb. 09 Citrine Global Corp. announced that it has received $0.055 million in funding CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 10.24 1.996 0.904 42.89 26.39 35.86
Enterprise Value (EV) 1 9.744 1.601 1.025 42.93 27.55 37.84
P/E ratio -3.17 x -0.86 x -0.43 x -2.51 x -5.84 x -13.6 x
Yield - - - - - -
Capitalization / Revenue - 7,939,173 x 6,063,380 x 3,771,266,620 x - -
EV / Revenue - 6,369,315 x 6,875,769 x 3,775,198,118 x - -
EV / EBITDA -3.58 x -0.72 x -0.57 x -5.13 x -8.27 x -19.1 x
EV / FCF -22.5 x -0.92 x -1.33 x 47.1 x 417 x 238 x
FCF Yield -4.45% -109% -75.3% 2.12% 0.24% 0.42%
Price to Book 20.2 x 2.69 x -2.2 x 30.6 x -18.3 x -14.5 x
Nbr of stocks (in thousands) 25,612 33,212 35,449 942,568 942,568 943,704
Reference price 2 0.4000 0.0601 0.0255 0.0455 0.0280 0.0380
Announcement Date 4/2/18 3/28/19 5/11/20 4/15/21 4/8/22 3/22/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - 0.2514 0.1491 0.0114 - -
EBITDA 1 -2.724 -2.235 -1.805 -8.363 -3.333 -1.984
EBIT 1 -2.745 -2.26 -1.836 -8.37 -3.335 -1.986
Operating Margin - -898.8% -1,231.34% -73,601.02% - -
Earnings before Tax (EBT) 1 -2.858 -2.157 -1.874 -8.639 -4.516 -2.645
Net income 1 -2.858 -2.157 -1.874 -8.639 -4.516 -2.645
Net margin - -857.97% -1,257.09% -75,968.69% - -
EPS 2 -0.1260 -0.0702 -0.0600 -0.0181 -0.004791 -0.002804
Free Cash Flow 1 -0.4337 -1.74 -0.772 0.9114 0.0661 0.1588
FCF margin - -692.06% -517.8% 8,014.75% - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/2/18 3/28/19 5/11/20 4/15/21 4/8/22 3/22/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 0.12 0.04 1.16 1.98
Net Cash position 1 0.5 0.39 - - - -
Leverage (Debt/EBITDA) - - -0.0671 x -0.005346 x -0.3483 x -0.998 x
Free Cash Flow 1 -0.43 -1.74 -0.77 0.91 0.07 0.16
ROE (net income / shareholders' equity) -914% -344% -594% -1,337% 24,411% 135%
ROA (Net income/ Total Assets) -270% -140% -162% -311% -100% -105%
Assets 1 1.06 1.543 1.156 2.776 4.507 2.519
Book Value Per Share 2 0.0200 0.0200 -0.0100 0 -0 -0
Cash Flow per Share 2 0.0200 0.0100 0 0 0 0
Capex 1 0.01 0.1 0.01 0.01 0.25 0
Capex / Sales - 38.98% 7.36% 51.27% - -
Announcement Date 4/2/18 3/28/19 5/11/20 4/15/21 4/8/22 3/22/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
CITRINE GLOBAL CORP. Stock Citrine Global Corp.
-37.50% 13.05M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. CTGL Stock
  4. Financials Citrine Global Corp.